Management of relapsed and refractory multiple myeloma in modern times: Incorporating new agents into decision-making-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of relapsed and refractory multiple myeloma in modern times: Incorporating new agents into decision-making

Published:2016-07-27 Issue:10 Volume:91 Page:1044-1051
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Clark Charles A.¹,Cornell Robert F.¹,Scott Emma C.²^ORCID,Chung Jae¹,Costa Luciano J.³

Affiliation:

1. Department of Medicine, Division of Hematology and Oncology; Vanderbilt University Medical Center; Nashville Tennessee

2. Division of Hematology and Medical Oncology; Knight Cancer Institute, Oregon Health and Science University; Portland Oregon

3. Division of Hematology and Oncology, Department of Medicine; University of Alabama at Birmingham; Birmingham Alabama

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24478/fullpdf

Reference44 articles.

1. Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: Increased options and increased complexity;Cornell;Bone Marrow Transplant,2016

2. Patterns of improved survival in patients with multiple myeloma in the twenty-first century: A population-based study;Turesson;J Clin Oncol,2010

3. Continued improvement in survival in multiple myeloma: Changes in early mortality and outcomes in older patients;Kumar;Leukemia,2014

4. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma;Bolli;Nat Commun,2014

5. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides;Egan;Blood,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India;Indian Journal of Hematology and Blood Transfusion;2024-04-01

2. KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma;Clinical Lymphoma Myeloma and Leukemia;2021-08

3. Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab;Journal of Blood Medicine;2021-05

4. Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia;Clinical Lymphoma Myeloma and Leukemia;2019-09

5. The impact of Daratumumab on transfusion service costs;Transfusion;2019-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3